|
|
|
Parkinson's disease
Parkinson's disease (PD) is a progressive movement disorder marked by tremor, rigidity, slow movements (bradykinesia), and postural instability. It occurs ...
From Gale Encyclopedia of Medicine,
4/6/01
by Richard Robinson
| |
|
|
Medication may improve symptoms in Parkinson's disease
Motor fluctuations are a major complication for patients with Parkinson's disease during treatment with levodopa (Larodopa). Adjuvant medications such ...
From American Family Physician,
11/1/05
by Anne D. Walling
| |
|
|
Developmental pesticide models of the Parkinson disease phenotype
It has been hypothesized that developmental insults could contribute to Parkinson disease (PD), a neurodegenerative disorder resulting from the loss ...
From Environmental Health Perspectives,
9/1/05
by Deborah A. Cory-Slechta
| |
|
|
Early environmental origins of neurodegenerative disease in later life
Parkinson disease (PD) and Alzheimer disease (AD), the two most common neurodegenerative disorders in American adults, are of purely genetic origin in a minority of cases and appear in most instanc
From Environmental Health Perspectives,
9/1/05
by Philip J. Landrigan
| |
|
|
Variant Creutzfeldt-Jakob disease death, United States
The only variant Creutzfeldt-Jakob disease (vCJD) patient identified in the United States died in 2004, and the diagnosis was confirmed by analysis of autopsy tissue. The patient likely acquired th
From Emerging Infectious Diseases,
9/1/05
by Ermias D. Belay
| |
|
|
Olanzapine and trihexyphenidyl-induced tardive dyskinesia
Byline: D. Mendhekar, A. Aggarwal Olanzapine, a thienobenzodiazepine derivative, is a second generation (atypical) antipsychotic agent, which has been proven efficient against the positive and ne
From Indian Journal of Pharmacology,
7/1/05
by D. Mendhekar
| |
|
|
Movement disorders
Movement disorders are a group of diseases and syndromes affecting the ability to produce and control movement.
From Gale Encyclopedia of Medicine,
4/6/01
by Richard Robinson
| |
|
|
Erythrocyte antioxidant enzymes in Parkinson's disease
Background & objectives: Oxidative stress is incriminated to play a central role in the pathogenesis of Parkinson's disease (PD). Oxidative stress, to ...
From Indian Journal of Medical Research,
2/1/05
by Abraham, S
| |
|